Summary
The global Darunavir Market is expected to witness a CAGR of xx% over the forecast period 2020-2026 and is expected to reach US$ xx million in 2026, from US$ xx million in 2019.
The Darunavir Market report highlights product development and growth strategies such as merger and acquisition adopted by market players along with SWOT Analysis, PEST and Porter’s Five Forces analyses of the Darunavir Market, which highlight the strengths, weaknesses, opportunities, and commination of key companies. Moreover, the report offers two distinct market forecasts, one from the perspective of the producer and another from that of the consumer.
The various contributors involved in the value chain of the product include manufacturers, suppliers, distributors, intermediaries, and customers.
The Key Manufacturers covered in this Report:-
- Janssen Therapeutics
- Mylan
- Teva
- Cipla
- Lupin
- Hetero
- ...
By the Product Type, the market is primarily segmented into:
By Applications, the market is segmented into:
The Report covers the following Regions:
- North America
- United States
- Canada
- Mexico
- Asia Pacific
- China
- Japan
- South Korea
- India
- Australia
- Indonesia
- Thailand
- Malaysia
- Philippines
- Vietnam
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Central & South America
- Middle East & Africa
- Turkey
- GCC Countries
- Egypt
- South Africa
Objective of the Darunavir Market Report:
- To assess the size of the market by value and volume
- Analyze the Darunavir Market in terms of regions and major countries
- Highlight recent developments and trends in the market
- Offer perceptive data regarding major market players in terms of key developments, strategies, and product portfolio
- Determine share of the Darunavir Market in terms of various segments such as by product type, application, and end-user
- Offer accurate projection of the market for the forecast period using state-of –the-art tools and the current primary and secondary research approaches
- Discuss major factors that impact growth of the Darunavir Market
The Darunavir Market engages the readers with all pivotal approaches to understand their position in the industry based on revenue or sales growth. The report efficiently evaluates the Darunavir Market from various dimensions to deliver an end-product that is informative, elaborate, and accurate and includes detailed market segmentation, regional analysis, and competition in the market. The information in the report is backed by annual company reports, financial reports, press releases, regulatory databases, government documents, and statistical databases.
For the data information by region, company, type and application, 2019 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Key Stakeholders:
- Material suppliers/wholesalers
- Market Distributors/traders
- Regulatory bodies
- Research organizations, and consulting firms
- Commercial research & developments (R&D)
- Trade associations and industry bodies
- Importers and exporters
- End-use industries
Available Customizations:
Custom research is one of the most crucial components of the business strategy that helps an organization gain insight into specific business sector, aligned with its specific area of interest. Thus, SMI offers more accurate, pragmatic, and actionable information specifically tailored to suit your business needs.
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Darunavir Revenue
1.4 Market Analysis by Type
1.4.1 Global Darunavir Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Tablet
1.4.3 Oral suspension
1.5 Market by Application
1.5.1 Global Darunavir Market Share by Application: 2020 VS 2026
1.5.2 Hospital
1.5.3 Drug store
1.6 Coronavirus Disease 2019 (Covid-19): Darunavir Industry Impact
1.6.1 How the Covid-19 is Affecting the Darunavir Industry
1.6.1.1 Darunavir Business Impact Assessment - Covid-19
1.6.1.2 Supply Chain Challenges
1.6.1.3 COVID-19s Impact On Crude Oil and Refined Products
1.6.2 Market Trends and Darunavir Potential Opportunities in the COVID-19 Landscape
1.6.3 Measures / Proposal against Covid-19
1.6.3.1 Government Measures to Combat Covid-19 Impact
1.6.3.2 Proposal for Darunavir Players to Combat Covid-19 Impact
1.7 Study Objectives
1.8 Years Considered
2 Global Growth Trends by Regions
2.1 Darunavir Market Perspective (2015-2026)
2.2 Darunavir Growth Trends by Regions
2.2.1 Darunavir Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Darunavir Historic Market Share by Regions (2015-2020)
2.2.3 Darunavir Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porters Five Forces Analysis
2.3.5 Darunavir Market Growth Strategy
2.3.6 Primary Interviews with Key Darunavir Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Darunavir Players by Market Size
3.1.1 Global Top Darunavir Players by Revenue (2015-2020)
3.1.2 Global Darunavir Revenue Market Share by Players (2015-2020)
3.1.3 Global Darunavir Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Darunavir Market Concentration Ratio
3.2.1 Global Darunavir Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Darunavir Revenue in 2019
3.3 Darunavir Key Players Head office and Area Served
3.4 Key Players Darunavir Product Solution and Service
3.5 Date of Enter into Darunavir Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2015-2026)
4.1 Global Darunavir Historic Market Size by Type (2015-2020)
4.2 Global Darunavir Forecasted Market Size by Type (2021-2026)
5 Darunavir Breakdown Data by Application (2015-2026)
5.1 Global Darunavir Market Size by Application (2015-2020)
5.2 Global Darunavir Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Darunavir Market Size (2015-2020)
6.2 Darunavir Key Players in North America (2019-2020)
6.3 North America Darunavir Market Size by Type (2015-2020)
6.4 North America Darunavir Market Size by Application (2015-2020)
7 Europe
7.1 Europe Darunavir Market Size (2015-2020)
7.2 Darunavir Key Players in Europe (2019-2020)
7.3 Europe Darunavir Market Size by Type (2015-2020)
7.4 Europe Darunavir Market Size by Application (2015-2020)
8 China
8.1 China Darunavir Market Size (2015-2020)
8.2 Darunavir Key Players in China (2019-2020)
8.3 China Darunavir Market Size by Type (2015-2020)
8.4 China Darunavir Market Size by Application (2015-2020)
9 Japan
9.1 Japan Darunavir Market Size (2015-2020)
9.2 Darunavir Key Players in Japan (2019-2020)
9.3 Japan Darunavir Market Size by Type (2015-2020)
9.4 Japan Darunavir Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Darunavir Market Size (2015-2020)
10.2 Darunavir Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Darunavir Market Size by Type (2015-2020)
10.4 Southeast Asia Darunavir Market Size by Application (2015-2020)
11 India
11.1 India Darunavir Market Size (2015-2020)
11.2 Darunavir Key Players in India (2019-2020)
11.3 India Darunavir Market Size by Type (2015-2020)
11.4 India Darunavir Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Darunavir Market Size (2015-2020)
12.2 Darunavir Key Players in Central & South America (2019-2020)
12.3 Central & South America Darunavir Market Size by Type (2015-2020)
12.4 Central & South America Darunavir Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Janssen Therapeutics
13.1.1 Janssen Therapeutics Company Details
13.1.2 Janssen Therapeutics Business Overview and Its Total Revenue
13.1.3 Janssen Therapeutics Darunavir Introduction
13.1.4 Janssen Therapeutics Revenue in Darunavir Business (2015-2020))
13.1.5 Janssen Therapeutics Recent Development
13.2 Mylan
13.2.1 Mylan Company Details
13.2.2 Mylan Business Overview and Its Total Revenue
13.2.3 Mylan Darunavir Introduction
13.2.4 Mylan Revenue in Darunavir Business (2015-2020)
13.2.5 Mylan Recent Development
13.3 Teva
13.3.1 Teva Company Details
13.3.2 Teva Business Overview and Its Total Revenue
13.3.3 Teva Darunavir Introduction
13.3.4 Teva Revenue in Darunavir Business (2015-2020)
13.3.5 Teva Recent Development
13.4 Cipla
13.4.1 Cipla Company Details
13.4.2 Cipla Business Overview and Its Total Revenue
13.4.3 Cipla Darunavir Introduction
13.4.4 Cipla Revenue in Darunavir Business (2015-2020)
13.4.5 Cipla Recent Development
13.5 Lupin
13.5.1 Lupin Company Details
13.5.2 Lupin Business Overview and Its Total Revenue
13.5.3 Lupin Darunavir Introduction
13.5.4 Lupin Revenue in Darunavir Business (2015-2020)
13.5.5 Lupin Recent Development
13.6 Hetero
13.6.1 Hetero Company Details
13.6.2 Hetero Business Overview and Its Total Revenue
13.6.3 Hetero Darunavir Introduction
13.6.4 Hetero Revenue in Darunavir Business (2015-2020)
13.6.5 Hetero Recent Development
14 Analyst's Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
List of Table
List of Tables
Table 1. Darunavir Key Market Segments
Table 2. Key Players Covered: Ranking by Darunavir Revenue
Table 3. Ranking of Global Top Darunavir Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Darunavir Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Tablet
Table 6. Key Players of Oral suspension
Table 7. COVID-19 Impact Global Market: (Four Darunavir Market Size Forecast Scenarios)
Table 8. Opportunities and Trends for Darunavir Players in the COVID-19 Landscape
Table 9. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 10. Key Regions/Countries Measures against Covid-19 Impact
Table 11. Proposal for Darunavir Players to Combat Covid-19 Impact
Table 12. Global Darunavir Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Darunavir Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Darunavir Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Darunavir Market Share by Regions (2015-2020)
Table 16. Global Darunavir Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Darunavir Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Darunavir Market Growth Strategy
Table 22. Main Points Interviewed from Key Darunavir Players
Table 23. Global Darunavir Revenue by Players (2015-2020) (Million US$)
Table 24. Global Darunavir Market Share by Players (2015-2020)
Table 25. Global Top Darunavir Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Darunavir as of 2019)
Table 26. Global Darunavir by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Darunavir Product Solution and Service
Table 29. Date of Enter into Darunavir Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Darunavir Market Size by Type (2015-2020) (Million US$)
Table 32. Global Darunavir Market Size Share by Type (2015-2020)
Table 33. Global Darunavir Revenue Market Share by Type (2021-2026)
Table 34. Global Darunavir Market Size Share by Application (2015-2020)
Table 35. Global Darunavir Market Size by Application (2015-2020) (Million US$)
Table 36. Global Darunavir Market Size Share by Application (2021-2026)
Table 37. North America Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Darunavir Market Share (2019-2020)
Table 39. North America Darunavir Market Size by Type (2015-2020) (Million US$)
Table 40. North America Darunavir Market Share by Type (2015-2020)
Table 41. North America Darunavir Market Size by Application (2015-2020) (Million US$)
Table 42. North America Darunavir Market Share by Application (2015-2020)
Table 43. Europe Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Darunavir Market Share (2019-2020)
Table 45. Europe Darunavir Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Darunavir Market Share by Type (2015-2020)
Table 47. Europe Darunavir Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Darunavir Market Share by Application (2015-2020)
Table 49. China Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 50. China Key Players Darunavir Market Share (2019-2020)
Table 51. China Darunavir Market Size by Type (2015-2020) (Million US$)
Table 52. China Darunavir Market Share by Type (2015-2020)
Table 53. China Darunavir Market Size by Application (2015-2020) (Million US$)
Table 54. China Darunavir Market Share by Application (2015-2020)
Table 55. Japan Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Darunavir Market Share (2019-2020)
Table 57. Japan Darunavir Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Darunavir Market Share by Type (2015-2020)
Table 59. Japan Darunavir Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Darunavir Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Darunavir Market Share (2019-2020)
Table 63. Southeast Asia Darunavir Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Darunavir Market Share by Type (2015-2020)
Table 65. Southeast Asia Darunavir Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Darunavir Market Share by Application (2015-2020)
Table 67. India Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 68. India Key Players Darunavir Market Share (2019-2020)
Table 69. India Darunavir Market Size by Type (2015-2020) (Million US$)
Table 70. India Darunavir Market Share by Type (2015-2020)
Table 71. India Darunavir Market Size by Application (2015-2020) (Million US$)
Table 72. India Darunavir Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Darunavir Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Darunavir Market Share (2019-2020)
Table 75. Central & South America Darunavir Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Darunavir Market Share by Type (2015-2020)
Table 77. Central & South America Darunavir Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Darunavir Market Share by Application (2015-2020)
Table 79. Janssen Therapeutics Company Details
Table 80. Janssen Therapeutics Business Overview
Table 81. Janssen Therapeutics Product
Table 82. Janssen Therapeutics Revenue in Darunavir Business (2015-2020) (Million US$)
Table 83. Janssen Therapeutics Recent Development
Table 84. Mylan Company Details
Table 85. Mylan Business Overview
Table 86. Mylan Product
Table 87. Mylan Revenue in Darunavir Business (2015-2020) (Million US$)
Table 88. Mylan Recent Development
Table 89. Teva Company Details
Table 90. Teva Business Overview
Table 91. Teva Product
Table 92. Teva Revenue in Darunavir Business (2015-2020) (Million US$)
Table 93. Teva Recent Development
Table 94. Cipla Company Details
Table 95. Cipla Business Overview
Table 96. Cipla Product
Table 97. Cipla Revenue in Darunavir Business (2015-2020) (Million US$)
Table 98. Cipla Recent Development
Table 99. Lupin Company Details
Table 100. Lupin Business Overview
Table 101. Lupin Product
Table 102. Lupin Revenue in Darunavir Business (2015-2020) (Million US$)
Table 103. Lupin Recent Development
Table 104. Hetero Company Details
Table 105. Hetero Business Overview
Table 106. Hetero Product
Table 107. Hetero Revenue in Darunavir Business (2015-2020) (Million US$)
Table 108. Hetero Recent Development
Table 109. Research Programs/Design for This Report
Table 110. Key Data Information from Secondary Sources
Table 111. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Darunavir Market Share by Type: 2020 VS 2026
Figure 2. Tablet Features
Figure 3. Oral suspension Features
Figure 4. Global Darunavir Market Share by Application: 2020 VS 2026
Figure 5. Hospital Case Studies
Figure 6. Drug store Case Studies
Figure 7. Darunavir Report Years Considered
Figure 8. Global Darunavir Market Size YoY Growth 2015-2026 (US$ Million)
Figure 9. Global Darunavir Market Share by Regions: 2020 VS 2026
Figure 10. Global Darunavir Market Share by Regions (2021-2026)
Figure 11. Porter's Five Forces Analysis
Figure 12. Global Darunavir Market Share by Players in 2019
Figure 13. Global Top Darunavir Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Darunavir as of 2019
Figure 14. The Top 10 and 5 Players Market Share by Darunavir Revenue in 2019
Figure 15. North America Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 16. Europe Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 17. China Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 18. Japan Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 19. Southeast Asia Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 20. India Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 21. Central & South America Darunavir Market Size YoY Growth (2015-2020) (Million US$)
Figure 22. Janssen Therapeutics Total Revenue (US$ Million): 2019 Compared with 2018
Figure 23. Janssen Therapeutics Revenue Growth Rate in Darunavir Business (2015-2020)
Figure 24. Mylan Total Revenue (US$ Million): 2019 Compared with 2018
Figure 25. Mylan Revenue Growth Rate in Darunavir Business (2015-2020)
Figure 26. Teva Total Revenue (US$ Million): 2019 Compared with 2018
Figure 27. Teva Revenue Growth Rate in Darunavir Business (2015-2020)
Figure 28. Cipla Total Revenue (US$ Million): 2019 Compared with 2018
Figure 29. Cipla Revenue Growth Rate in Darunavir Business (2015-2020)
Figure 30. Lupin Total Revenue (US$ Million): 2019 Compared with 2018
Figure 31. Lupin Revenue Growth Rate in Darunavir Business (2015-2020)
Figure 32. Hetero Total Revenue (US$ Million): 2019 Compared with 2018
Figure 33. Hetero Revenue Growth Rate in Darunavir Business (2015-2020)
Figure 34. Bottom-up and Top-down Approaches for This Report
Figure 35. Data Triangulation
Figure 36. Key Executives Interviewed